Detalhe da pesquisa
1.
Effectiveness of Adjunctive High-Dose Infliximab Therapy to Improve Disability-Free Survival Among Patients With Severe Central Nervous System Tuberculosis: A Matched Retrospective Cohort Study.
Clin Infect Dis
; 77(10): 1460-1467, 2023 11 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-37405816